Liqun Zhou

1.5k citations
38 papers · 893 indexed · 1 hit paper · h-index 14

Liqun Zhou

32 papers receiving 884 citations

Hit Papers

Unadjuvanted intranasal spike vaccine elicits protective ...209202220262023202450100150200

Peers

Liqun Zhou
Comparison fields: 5 of 108
  • Health, Toxicology and Mutagenesis 148
  • Immunology 215
  • Cell Biology 156
  • Infectious Diseases 149
  • Pollution 70
Replace Ayako Kobayashi with:
Ayako Kobayashi Japan
Andrea Lehmann Germany
Karen Elizabeth Nava‐Castro Mexico
Yulin Zhou China
Karin Holm Sweden
Mónica Varela Netherlands
Feng Chi China
Hanseul Oh South Korea
Xiaoli Qin China
Liqun Zhou relative to Ayako Kobayashi Japan Ayako Kobayashi's profile →
Citations per field
00.5×
Ayako Kobayashi · 1×
Citations per year

Countries citing papers authored by Liqun Zhou

Since Specialization
Citations

This map shows the geographic impact of Liqun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqun Zhou more than expected).

Fields of papers citing papers by Liqun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqun Zhou. The network helps show where Liqun Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Liqun Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liqun Zhou Line = papers co-authored together Liqun Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20241
5 20240
6 20240
7 20231
8 20232
9 20237
10
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecovirusesbreakdown →
2022209
11 202229
12 20222
13 2021113
14 20215
15 20215
16 202114
17 202027
18 201990
19 201970
20 200355

About Liqun Zhou

Liqun Zhou is a scholar working on Urology, Obstetrics and Gynecology and Biophysics, having authored 38 papers that have together received 893 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Zebrafish Biomedical Research Applications (4 papers), Environmental Toxicology and Ecotoxicology (4 papers), Epigenetics and DNA Methylation (4 papers), Urinary and Genital Oncology Studies (4 papers), Ferroptosis and cancer prognosis (3 papers), Ureteral procedures and complications (3 papers) and Urological Disorders and Treatments (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (148 citations), Immunology (215 citations) and Cell Biology (156 citations). Liqun Zhou has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Zigang Cao, Xinjun Liao, Zhen Meng, Huiqiang Lu, Honglei Wang, Shouhua Zhang, Tianyang Mao, Akiko Iwasaki, Alexandra Suberi and Mario A. Peña-Hernández. Their work appears in journals such as Science, The Journal of Immunology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026